MedPath

Heart Inflammation and Mental Stress Study

Not Applicable
Completed
Conditions
Hypertension
Registration Number
NCT03695146
Lead Sponsor
University of Miami
Brief Summary

The aim of the study is to investigate the neural underpinnings of cardiovascular reactivity to mental stress as a function of HIV and hypertensive risk.

Detailed Description

The main objectives of the study are to assess (1) patterns of brain activity/connectivity that confers greater cardio-autonomic/emotion regulation, (e.g., heart rate variability, blood pressure reactivity, inflammatory-immune activation, etc.), during rest, mental stress, and anger-related distress, (2) whether changes in breathing pace mitigate task-based effects on cardio-autonomic-immune regulation, and (3) whether these patterns vary as a function of HIV or pre-hypertensive (HTN) status-related changes to the brain structures underlying cardioautonomic and emotion regulation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in heart rate variabilityBaseline, pre-intervention and up to 60 minutes post-intervention

Heart rate variability will be measured using a standard electrocardiogram to detect variability in R -to-R intervals.

Secondary Outcome Measures
NameTimeMethod
Change in cytokine expression in peripheral blood mononuclear cellsBaseline, pre-intervention and up to 60 minutes post-intervention

Peripheral blood will be drawn and mononuclear cells isolated and incubated with lipopolysaccharide to induce inflammatory cytokine expression. The change in cytokine expression will be quantified as a function of time.

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

University of Miami
🇺🇸Miami, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.